Omne Possibile is a pioneering, global technological leader in XNA, creating customizable structures to outperform current DNA and RNA technologies. Its goal is to harness the transformative power of XNA in areas including healthcare, information technology and smart materials. The Company’s initial focus is on development of XNA polymers for information storage and XNA building blocks for improved messenger therapeutics. Omne Possibile has R&D hubs in Leuven, Belgium, and Basel, Switzerland. It was founded by leading European synthetic biologists and is supported by a world class scientific advisory board. For more information, please visit www.omnepossibile.com
Company Details
- Employees
- 3
- Address
- Tiergartenrain 3, Basel,4054,switzerland
- Industry
- Biotechnology
- Website
- https://www.omnepossibile.com/
- Keywords
- The Spinoza Foundation.
- HQ
- Basel
Omne Possibile Questions
Omne Possibile's website is https://www.omnepossibile.com/
Omne Possibile's LinkedIn profile is https://ch.linkedin.com/company/omnepossibile
Omne Possibile has
3 employees.
View email and phone details for 3
employees at Omne Possibile.
Omne Possibile's industry is
Biotechnology
Omne Possibile's top competitors are
Tolremo Therapeutics,
Alentis Therapeutics,
Fondaco Synbio,
Nuclid,
Seal Therapeutics Ag,
Mouradian Foundation,
The Spinoza Foundation,
Forx Therapeutics,
Eurekare - Investing In Synbio Innovation,
Synendos Therapeutics Ag.
Omne Possibile's categories are Biotechnology
